Level Biotechnology Inc. (TPEX:3118)

Level Biotechnology Revenue

Level Biotechnology had revenue of 158.86M TWD in the quarter ending March 31, 2026, a decrease of -10.19%. This brings the company's revenue in the last twelve months to 718.58M, down -1.56% year-over-year. In the year 2025, Level Biotechnology had annual revenue of 736.59M with 0.72% growth.

• Revenue (ttm): 718.58M
• Revenue Growth: -1.56%
• P/S Ratio: 1.43
• Revenue / Employee: 5.61M
• Employees: 128
• Market Cap: 1.03B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	736.59M	5.25M	0.72%
Dec 31, 2024	731.35M	70.74M	10.71%
Dec 31, 2023	660.61M	67.60M	11.40%
Dec 31, 2022	593.01M	-84.27M	-12.44%
Dec 31, 2021	677.28M	4.79M	0.71%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error